Highlights
NASDAQ: ADMS       Adamas Pharma
Last Price Today's Change   Day's Range   Trading Volume
5.28   -0.04 (0.75%)  5.22 - 5.38  58,500

Overview

 
Avg Volume (4 weeks):338,800
4 Weeks Range:3.65 - 5.72
4 Weeks Price Volatility (%):
78.74%
52 Weeks Range:3.35 - 12.57
52 Weeks Price Volatility (%):
20.93%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Adamas Pharmaceuticals Inc was incorporated in the State of Delaware on November 15, 2000. It is a pharmaceutical company focused on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The Company is developing its wholly-owned product candidate, ADS-5102 (amantadine hydrochloride) for a complication associated with the treatment of Parkinson's disease known as levodopa-induced dyskinesia. The Company's portfolio also includes two drugs commercially available in the United States for indications relating to Alzheimer's disease: Namzaric capsules and Namenda XR extended release capsules.

  Be the first to like this.
 


 

1649  3823  593  2912 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 AABA 19.630.00 
 ACB 3.00+0.36 
 AMD 39.84-1.14 
 UBER 29.425+1.395 
 M 14.56-0.46 
 CHK 0.582+0.012 
 HEPA 3.73+1.31 
 SCHW 48.52+3.77 
 GGB 3.779+0.179 
Partners & Brokers